Search by Drug Name or NDC

    NDC 00024-5926-05 ADMELOG 100 U/mL Details

    ADMELOG 100 U/mL

    ADMELOG is a INTRAVENOUS; SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sanofi-Aventis U.S. LLC. The primary component is INSULIN LISPRO.

    Product Information

    NDC 00024-5926
    Product ID 0024-5926_5c8efb5f-4957-428e-ad2a-a2a9a28ca2fd
    Associated GPIs 27104005002022
    GCN Sequence Number 027413
    GCN Sequence Number Description insulin lispro VIAL 100/ML SUBCUT
    HIC3 C4G
    HIC3 Description INSULINS
    GCN 05679
    HICL Sequence Number 011528
    HICL Sequence Number Description INSULIN LISPRO
    Brand/Generic Brand
    Proprietary Name ADMELOG
    Proprietary Name Suffix n/a
    Non-Proprietary Name insulin lispro
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units U/mL
    Substance Name INSULIN LISPRO
    Labeler Name Sanofi-Aventis U.S. LLC
    Pharmaceutical Class Insulin Analog [EPC], Insulin [Chemical/Ingredient]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA209196
    Listing Certified Through 2024-12-31

    Package

    NDC 00024-5926-05 (00024592605)

    NDC Package Code 0024-5926-05
    Billing NDC 00024592605
    Package 1 VIAL in 1 CARTON (0024-5926-05) / 3 mL in 1 VIAL
    Marketing Start Date 2018-10-19
    NDC Exclude Flag N
    Pricing Information N/A